In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 6, 2004, Pages 1086-1089

  Garcia Effron, Guillermo ^a   Gomez Lopez, Alicia ^a   Mellado, Emilia ^a   Monzon, Araceli ^a   Rodriguez Tudela, Juan L ^a   Cuenca Estrella, Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Allylamines; Antifungals; Aspergillus spp.; Spanish filamentous fungi

Indexed keywords

ALLYLAMINE; AMPHOTERICIN B; ITRACONAZOLE; TERBINAFINE; VORICONAZOLE;

ACREMONIUM; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CLINICAL LABORATORY; CONTROLLED STUDY; DERMATOPHYTE; DILUTION; FUNGAL STRAIN; FUNGUS ISOLATION; FUSARIUM; GENUS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MUCORALES; NONHUMAN; PAECILOMYCES; PENICILLIUM; SCEDOSPORIUM; SCOPULARIOPSIS BREVICAULIS; SPECIES DIFFERENCE; STATISTICAL SIGNIFICANCE; TRICHODERMA;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; FUNGI; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; PYRIMIDINES; SPAIN; TRIAZOLES;

EID: 3042544365     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh228     Document Type: Article

References (14)

1. Tosti, A., Piraccini, B. M. & Lorenzi, S. (2000). Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. Journal of the American Academy of Dermatology 42, 217-24.
2. Schiraldi, G. F., Cicero, S. L., Colombo, M. D. et al. (1996). Refractory pulmonary aspergillosis: compassionate trial with terbinafine. British Journal of Dermatology 134, Suppl. 46, 25-9.
3. Hay, R. J. (1999). Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. British Journal of Dermatology 141, Suppl. 56, 36-40.
4. Howden, B. P., Slavin, M. A., Schwarer, A. P. et al. (2003). Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. European Journal of Clinical Microbiology and Infectious Diseases 22, 111-3.
5. Jessup, C. J., Ryder, N. S. & Ghannoum, M. A. (2000). An evaluation of the in vitro activity of terbinafine. Medical Mycology 38, 155-9.
6. Moore, C. B., Walls, C. M. & Denning, D. W. (2001). In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B. Antimicrobial Agents and Chemotherapy 45, 1882-5.
7. National Committee for Clinical Laboratory Standards. (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi: Approved Standard M38-A. NCCLS, Wayne, PA, USA.
8. Cuenca-Estrella, M., Diaz-Guerra, T. M., Mellado, E. et al. (2001). Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp. Journal of Clinical Microbiology 39, 525-32.
9. Rodriguez-Tudela, J. L., Chryssanthou, E., Petrikkou, E. et al. (2003). Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. Journal of Clinical Microbiology 41, 5236-7.
10. Denning, D. W., Radford, S. A., Oakley, K. L. et al. (1997). Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. Journal of Antimicrobial Chemotherapy 40, 401-14.
11. Gomez-Lopez, A., Garcia-Effron, G., Mellado, E. et al. (2003). In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrobial Agents and Chemotherapy 47, 3085-8.
12. Steinbach, W. J., Stevens, D. A. & Denning, D. W. (2003). Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clinical Infectious Diseases 37, Suppl. 3, S188-224.
13. Clark, N. M. (1999). Paecilomyces lilacinus infection in a heart transplant recipient and successful treatment with terbinaline. Clinical Infectious Diseases 28, 1169-70.
14. Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E. et al. (2003). Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrobial Agents and Chemotherapy 47, 2339-41.